Related Experiment Videos
Chronic interstitial lung disease in children.
1Department of Pediatrics, University of Padova, Italy. barbato@child.pedi.unipd.it
Paediatric Respiratory Reviews
|January 18, 2003
Summary
Pediatric chronic interstitial lung disease (ILD) is rare but serious, often progressing to pulmonary fibrosis. Diagnosis involves non-invasive and invasive methods, with lung biopsy as the gold standard for classifying idiopathic forms.
Area of Science:
- Pediatric Pulmonology
- Interstitial Lung Diseases
- Pediatric Pathology
Background:
- Chronic interstitial lung disease (ILD) in children is uncommon but carries significant morbidity and mortality.
- Multiple etiological agents contribute to ILD, leading to diverse forms characterized by pulmonary fibrosis.
- Idiopathic interstitial pneumonia (IIP) is diagnosed when the etiology remains unknown.
Purpose of the Study:
- To review the diagnostic approaches for pediatric ILD.
- To discuss the classification of idiopathic interstitial pneumonias.
- To outline current therapeutic strategies and prognosis for pediatric ILD.
Main Methods:
- Non-invasive diagnostic methods include clinical history, pulmonary function tests, chest X-ray, and high-resolution CT scans.
- Invasive techniques such as bronchoalveolar lavage and various lung biopsies (transbronchial, video-assisted thoracoscopic, open lung) are employed when non-invasive methods are insufficient.
- Lung biopsy is considered the gold standard for diagnosis and classification of idiopathic ILD subtypes.
Main Results:
- Diagnosis of pediatric ILD requires a combination of non-invasive and invasive techniques.
- Lung biopsy is crucial for accurate classification of idiopathic interstitial pneumonia subtypes.
- Current treatments often involve oral steroids and hydroxychloroquine sulfate.
Conclusions:
- Pediatric ILD presents a diagnostic challenge, necessitating a multimodal approach.
- Effective classification of idiopathic forms relies on histopathological examination of lung tissue.
- The prognosis for pediatric ILD is frequently poor, highlighting the need for further research and improved therapies.